Clinical Trials Browser

OTHER × Disease Progression × cemiplimab × Clear all

NCT07274384 2025-12-10

HYPERBOLIC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Neoplasms, Disease Progression